Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

12
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
12
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

11
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
11

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age and sex-based differences in therapy preferences among patients with cancer: evidence from a novel therapy preference scale.

Ecancermedicalscience·2026
Same author

Sustainable valorization of rice straw lignin into functional derivatives for efficient remediation of organic pollutants and heavy metal ions from wastewater.

International journal of biological macromolecules·2026
Same author

Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations.

Cureus·2026
Same author

Novel treatment strategies in acute myeloid leukemia.

Blood research·2026
Same author

Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience.

Annals of hematology·2026
Same author

Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple Myeloma.

Clinical epidemiology·2026

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.4K

Venous Thromboembolism Risk Assessment in Hospitalized Cancer Patients: A Single Center Study.

Supratik Rayamajhi1,2, Shiva Shrotriya1,2,3, Manoj Rai1,4

  • 1Department of Internal Medicine, Michigan State University, East Lansing, MI, USA.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|November 1, 2023
PubMed
Summary

Hospitalized cancer patients with low hemoglobin or renal disease face higher venous thromboembolism (VTE) risks. A new risk-assessment model (RAM) shows promise for identifying patients unlikely to develop VTE.

Keywords:
VTE RAMVTE risk predictorscancer patientsinpatient settingvenous thromboembolism

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

13.5K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.3K

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.4K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

13.5K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.3K

Area of Science:

  • Oncology
  • Hematology
  • Clinical Medicine

Background:

  • Venous thromboembolism (VTE) is a significant complication in hospitalized cancer patients.
  • Identifying patients at high risk for VTE is crucial for effective prevention and management.
  • Existing risk assessment models (RAMs) may require refinement for this specific population.

Purpose of the Study:

  • To identify key predictors of VTE in hospitalized cancer patients.
  • To develop and evaluate a novel VTE risk-assessment model (RAM) using demographic, clinical, and laboratory data.
  • To assess the model's performance in predicting VTE risk within this cohort.

Main Methods:

  • Retrospective analysis of demographic, clinical, and laboratory data from hospitalized cancer patients.
  • Development of a multivariable predictive model for VTE.
  • Evaluation of the model's discriminatory performance, sensitivity, specificity, and predictive values.

Main Results:

  • Patients categorized as very high or high risk, those with low hemoglobin levels, and patients with renal disease demonstrated a significantly increased risk of VTE.
  • The developed VTE RAM exhibited moderate discriminatory performance, high specificity, and a high negative predictive value.
  • The model's positive predictive value and sensitivity were limited by the low prevalence of VTE in the study population.

Conclusions:

  • Low hemoglobin and renal disease are significant predictors of VTE in hospitalized cancer patients.
  • The developed VTE RAM shows potential for effectively ruling out VTE risk in a majority of patients.
  • Further validation and refinement are necessary to improve the model's sensitivity and positive predictive value for broader clinical application.